Xbrane Biopharma AB (publ)

SSE:XBRANE.ST

2.085 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q3
Operating Activities:
Net Income -70.502-97.106-92.64-81.23-91.011-58.397-60.733-41.884-33.775-36.122-32.471-45.47-59.168-51.267-63.053-57.742-53.397-48.887-55.926-32.398-44.399-33.313-32.53160.325-31.992-8.916-19.157-9.092-6.63-10.105-10.163-10.09-7.539-5.43-5.035-4.101-1.333-1.082-1.321-0.616
Depreciation & Amortization 8.9549.09917.2828.1227.5948.864.3054.3544.0333.8843.8923.2063.6252.4162.5161.0951.6241.6540.8662.1151.8471.6970.0271.2041.261.0521.360.6592.4052.3062.392.1912.4191.5391.3950.0160.03100.0160.016
Deferred Income Tax 00-1.833000-13.15000000000000000000000000000000000
Stock Based Compensation 001.8330008.8450006.7980002.040002.410001.190000.4330000000000000
Change In Working Capital -28.061-30.013-5.526-44.434-59.634-8.162-56.166-36.881-12.35774.672-34.116-19.958-41.46857.127-8.37-43.79162.506-31.9243.429-53.26427.106-24.54167.043-23.74413.261-1.6916.2990.08-0.313-1.355-4.356-3.051-3.704-3.565-5.0443.048-0.180.196-0.1960.142
Accounts Receivables -89.35528.48634.83911.663-111.452-20.182-18.02323.227-51.38547.88-55.702-24.097-19.31638.029-33.41417.29614.02-49.22746.858-45.37810.199-39.96559.921-106.6415.172-4.812-2.7881.177-0.579-5.25-2.572-2.124-0.4090-0.039-0.031-0.09-0.0040.0050.075
Change In Inventory -52.535-80.42826.806-38.453-41.474-3.475-50.26000000000004.242-0.021-0.936-3.285-2.8211.458-0.802-0.1154.0851.1770.6430.2350.372-0.0640.209-2.853-0.16100000
Change In Accounts Payables 113.82921.929-67.171-19.04493.29215.49512.117-60.10839.02826.79221.5864.139-22.15219.09800000000000000000000000000
Other Working Capital 113.829022.5721.40017.82900022.67100032.69700039.187-53.24328.042-21.25669.864-25.20214.063-1.5762.214-1.096-0.956-1.59-4.729-2.987-3.913-0.712-5.1432.81-0.0410.206-0.2430.067
Other Non Cash Items 35.74553.024-2.075-7.8690.9711.0361.842-0.467-7.3566.9226.2193.122-4.2462.0863.84-1.866.738-2.4718.7531.785-0.4754.6543.275-1.4431.4281.6931.7561.062-2.37-0.199-0.0780.382-0.018-0.101-0.2960.002-0.002-0.0020.004-0.097
Operating Cash Flow -99.531-113.207-81.126-125.411-142.08-56.663-115.057-74.878-49.45545.472-60.368-62.306-104.8827.946-67.583-103.39315.847-83.2776.256-83.877-17.768-53.237.78735.138-17.303-8.914-11.102-7.95-6.907-9.353-12.207-10.568-8.842-7.556-8.981-1.035-1.484-0.887-1.498-0.555
Investing Activities:
Investments In Property Plant And Equipment -10.547-0.501-0.176-0.187-1.944-15.862-9.406-11.456-7.685-31.578-25.9-37.526-5.177-8.7470.009-3.788-0.034-0.042-0.17-0.209-0.451-0.357-0.184-0.731-0.662-0.021-2.989-0.263-0.26-0.091-0.108-2.185-2.416-7.631-1.14600000
Acquisitions Net 000000000000000000000000000000000.579-0.57900.0190000
Purchases Of Investments 0000000000000000000000000000000000000000
Sales Maturities Of Investments 0000000000000000000000000000000000000000
Other Investing Activites -10.547000-1.4-9.978-7.7260.001-0.001-29.932-22.75-26.92200000000000000-4.2970.21-00.6940.321-0.768-0.635-1.853-1.1460.0190000
Investing Cash Flow -10.547-0.501-0.176-0.187-1.944-15.862-9.406-11.455-7.686-31.578-25.9-37.526-5.177-8.7470.009-3.788-0.034-0.042-0.17-0.209-0.451-0.357-0.184-0.731-0.662-0.021-4.297-0.053-0.260.603-0.108-2.185-3.05-7.631-1.1460.0190000
Financing Activities:
Debt Repayment -62.499-3.665-10.417-10.416-2.466-2.43-2.207-2.175-2.022-1.933-2.353-1.824-1.952-1.045-0.777-0.786-0.766-0.012-0.034-0.036-0.035-0.035-0.033-0.079-14.861-0.041-0.366-0.452-0.146-0.132-0.418-0.017-0.024-10000000
Common Stock Issued -19.93319.69300.0181200170.52700.02400.013380.4450.42502000146.4470091.131161.3260003.2502.554017.0040-0.1190.241090.696000000
Common Stock Repurchased 000000000000000000000000000-0.2870000-0.1310000000
Dividends Paid 0000000000000000000000000000000000000000
Other Financing Activities 0.001319.693-3.684-12.873220.964-2.43-15.557-2.175-2.022-1.933-2.341-26.069-1.952-1.144-11.024-0.786-11.103-0.798-0.809-16.045-19.115-0.307-0.0629.92914.8619.906-2.543-00.0730-0.1510.241-0.0240.414100000.180
Financing Cash Flow -85.967316.028-14.101-23.271338.498-2.43154.97-2.175-1.998-1.933-2.341354.376-1.527-1.144188.976-0.786135.344-0.81-0.84375.05142.176-0.342-0.0959.8518.1119.865-0.355-0.73917.076-0.132-0.27-0.017-0.02481.109100000.180
Other Information:
Effect Of Forex Changes On Cash -1.0621.931-6.5780.3722.228-0.507-2.1933.3547.876-5.0031.0780.0561.312-1.054-2.03-0.771-3.124.402-3.241-0.1783.136-2.757-0.8450.7980.180.0960.0330000-0-00-000000
Net Change In Cash -196.922204.356-101.882165.879196.894-75.24828.759162.687-51.3746.279-88.255254.999-110.809-3.895119.371-108.738148.035-79.7262.002-9.215127.093-56.65536.66145.0560.32511.027-15.721-8.7419.91-8.883-12.585-12.771-11.91665.922-0.127-1.015-1.484-0.887-1.318-0.555
Cash At End Of Period 72.835269.75865.402167.284315.64118.746193.994165.235250.085301.459295.18383.435129.332239.244243.139123.768232.50684.471164.197162.195171.4144.317100.97264.31119.25518.937.90323.62432.36522.45631.33843.92356.69468.612.6882.8153.835.3146.2017.519